Sketch by Duncan Smith

In two articles posted this week to Forbes, Dr. Madhukar Pai outlines the great threat posed by drug-resistant tuberculosis (DR-TB), while also offering a glimmer of hope in describing the efforts of a London team in using mycobacteriophages to treat M. abscessus, which closely resembles DR-TB. The articles come on the heels of a report put out by The Economist Intelligence Unit.


May 16, 2019